Vaccines against the bovine viral diarrhoea virus (BVDV), the bovine Herpesvirus 1 (BoHV 1) and the bovine respiratory syncytial virus (BRSV), were evaluated in the context of vaccine testing for licensing purposes and field use. Challenge models for the three viruses were investigated. While clinical signs and high levels of virus excretion could be reproduced after infection with BoHV-1 wild type, disease was less pronounced and virus titers were lower after infection with BRSV and BVDV field viruses. Additional parameters need to be assessed to allow conclusions on vaccine efficacy against these two viruses. Contact with a PI animal was found to be suitable as challenge procedure for BVDV 2 but attempts to develop a dual fetal challenge procedure for BVDV 1 and 2 failed. The immune response after combined application of a live IBR marker vaccine and inactivated BVD or BRSV vaccines was determined. Possibilities for interference of vaccination with the interpretation of antibody tests in BVDV and IBR disease control programs were investigated. Finally, potential risks of the unintended immunisation by use of vaccines were evaluated.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vaccines against the bovine viral diarrhoea virus (BVDV), the bovine Herpesvirus 1 (BoHV 1) and the bovine respiratory syncytial virus (BRSV), were evaluated in the context of vaccine testing for licensing purposes and field use. Challenge models for the three viruses were investigated. While clinical signs and high levels of virus excretion could be reproduced after infection with BoHV-1 wild type, disease was less pronounced and virus titers were lower after infection with BRSV and BVDV field viruses. Additional parameters need to be assessed to allow conclusions on vaccine efficacy against these two viruses. Contact with a PI animal was found to be suitable as challenge procedure for BVDV 2 but attempts to develop a dual fetal challenge procedure for BVDV 1 and 2 failed. The immune response after combined application of a live IBR marker vaccine and inactivated BVD or BRSV vaccines was determined. Possibilities for interference of vaccination with the interpretation of antibody tests in BVDV and IBR disease control programs were investigated. Finally, potential risks of the unintended immunisation by use of vaccines were evaluated.
Birgit Makoschey holds a veterinary degree from the University of Veterinary Medicine Hannover. She prepared her thesis on Immunodeficiency viruses at the German Primate Center. Birgit Makoschey worked as research scientist in the Virolgical R&D and as Technical Director at Global Marketing of Intervet Int. in Boxmeer (The Netherlands).
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur DB-9783838120928
Quantité disponible : 1 disponible(s)
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur DB-9783838120928
Quantité disponible : 1 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 116 pages. 8.66x5.91x0.27 inches. In Stock. N° de réf. du vendeur __3838120922
Quantité disponible : 1 disponible(s)
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Vaccines against the bovine viral diarrhoea virus (BVDV), the bovine Herpesvirus 1 (BoHV 1) and the bovine respiratory syncytial virus (BRSV), were evaluated in the context of vaccine testing for licensing purposes and field use. Challenge models for the three viruses were investigated. While clinical signs and high levels of virus excretion could be reproduced after infection with BoHV-1 wild type, disease was less pronounced and virus titers were lower after infection with BRSV and BVDV field viruses. Additional parameters need to be assessed to allow conclusions on vaccine efficacy against these two viruses. Contact with a PI animal was found to be suitable as challenge procedure for BVDV 2 but attempts to develop a dual fetal challenge procedure for BVDV 1 and 2 failed. The immune response after combined application of a live IBR marker vaccine and inactivated BVD or BRSV vaccines was determined. Possibilities for interference of vaccination with the interpretation of antibody tests in BVDV and IBR disease control programs were investigated. Finally, potential risks of the unintended immunisation by use of vaccines were evaluated. 116 pp. Englisch. N° de réf. du vendeur 9783838120928
Quantité disponible : 1 disponible(s)
Vendeur : Rheinberg-Buch Andreas Meier eK, Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Vaccines against the bovine viral diarrhoea virus (BVDV), the bovine Herpesvirus 1 (BoHV 1) and the bovine respiratory syncytial virus (BRSV), were evaluated in the context of vaccine testing for licensing purposes and field use. Challenge models for the three viruses were investigated. While clinical signs and high levels of virus excretion could be reproduced after infection with BoHV-1 wild type, disease was less pronounced and virus titers were lower after infection with BRSV and BVDV field viruses. Additional parameters need to be assessed to allow conclusions on vaccine efficacy against these two viruses. Contact with a PI animal was found to be suitable as challenge procedure for BVDV 2 but attempts to develop a dual fetal challenge procedure for BVDV 1 and 2 failed. The immune response after combined application of a live IBR marker vaccine and inactivated BVD or BRSV vaccines was determined. Possibilities for interference of vaccination with the interpretation of antibody tests in BVDV and IBR disease control programs were investigated. Finally, potential risks of the unintended immunisation by use of vaccines were evaluated. 116 pp. Englisch. N° de réf. du vendeur 9783838120928
Quantité disponible : 1 disponible(s)
Vendeur : Wegmann1855, Zwiesel, Allemagne
Taschenbuch. Etat : Neu. Neuware -Vaccines against the bovine viral diarrhoea virus (BVDV), the bovine Herpesvirus 1 (BoHV 1) and the bovine respiratory syncytial virus (BRSV), were evaluated in the context of vaccine testing for licensing purposes and field use. Challenge models for the three viruses were investigated. While clinical signs and high levels of virus excretion could be reproduced after infection with BoHV-1 wild type, disease was less pronounced and virus titers were lower after infection with BRSV and BVDV field viruses. Additional parameters need to be assessed to allow conclusions on vaccine efficacy against these two viruses. Contact with a PI animal was found to be suitable as challenge procedure for BVDV 2 but attempts to develop a dual fetal challenge procedure for BVDV 1 and 2 failed. The immune response after combined application of a live IBR marker vaccine and inactivated BVD or BRSV vaccines was determined. Possibilities for interference of vaccination with the interpretation of antibody tests in BVDV and IBR disease control programs were investigated. Finally, potential risks of the unintended immunisation by use of vaccines were evaluated. N° de réf. du vendeur 9783838120928
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Makoschey BirgitBirgit Makoschey holds a veterinary degree from the University of Veterinary Medicine Hannover. She prepared her thesis on Immunodeficiency viruses at the German Primate Center. Birgit Makoschey worked as research sci. N° de réf. du vendeur 5406444
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. Neuware - Vaccines against the bovine viral diarrhoea virus (BVDV), the bovine Herpesvirus 1 (BoHV 1) and the bovine respiratory syncytial virus (BRSV), were evaluated in the context of vaccine testing for licensing purposes and field use. Challenge models for the three viruses were investigated. While clinical signs and high levels of virus excretion could be reproduced after infection with BoHV-1 wild type, disease was less pronounced and virus titers were lower after infection with BRSV and BVDV field viruses. Additional parameters need to be assessed to allow conclusions on vaccine efficacy against these two viruses. Contact with a PI animal was found to be suitable as challenge procedure for BVDV 2 but attempts to develop a dual fetal challenge procedure for BVDV 1 and 2 failed. The immune response after combined application of a live IBR marker vaccine and inactivated BVD or BRSV vaccines was determined. Possibilities for interference of vaccination with the interpretation of antibody tests in BVDV and IBR disease control programs were investigated. Finally, potential risks of the unintended immunisation by use of vaccines were evaluated. N° de réf. du vendeur 9783838120928
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Vaccines against the bovine viral diarrhoea virus (BVDV), the bovine Herpesvirus 1 (BoHV 1) and the bovine respiratory syncytial virus (BRSV), were evaluated in the context of vaccine testing for licensing purposes and field use. Challenge models for the three viruses were investigated. While clinical signs and high levels of virus excretion could be reproduced after infection with BoHV-1 wild type, disease was less pronounced and virus titers were lower after infection with BRSV and BVDV field viruses. Additional parameters need to be assessed to allow conclusions on vaccine efficacy against these two viruses. Contact with a PI animal was found to be suitable as challenge procedure for BVDV 2 but attempts to develop a dual fetal challenge procedure for BVDV 1 and 2 failed. The immune response after combined application of a live IBR marker vaccine and inactivated BVD or BRSV vaccines was determined. Possibilities for interference of vaccination with the interpretation of antibody tests in BVDV and IBR disease control programs were investigated. Finally, potential risks of the unintended immunisation by use of vaccines were evaluated.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 116 pp. Englisch. N° de réf. du vendeur 9783838120928
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Investigations on efficacy and practical use of viral cattle vaccines | Efficacy testing and practical application of viral cattle vaccines [Wirksamkeitsprüfung und praktische Anwendung viraler Rinderimpfstoffe] | Birgit Makoschey | Taschenbuch | 116 S. | Englisch | 2015 | Südwestdeutscher Verlag für Hochschulschriften | EAN 9783838120928 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu. N° de réf. du vendeur 107244281
Quantité disponible : 1 disponible(s)